Literature DB >> 12801449

Acute coronary syndromes in patients with diabetes mellitus: diagnosis, prognosis, and current management strategies.

Rhoda Brosnan1, L Kristin Newby.   

Abstract

The incidence of type-2 diabetes mellitus is rising rapidly both in the United States and worldwide. Because of its presence in so many patients with acute coronary syndromes, it is becoming essential for cardiologists to understand the basic pathophysiology of insulin resistance, its role in the development of type-2 diabetes, and its association with accelerated atherosclerosis. Because diabetes imparts a worse prognosis among patients with acute coronary syndromes, these patients warrant aggressive antiplatelet and antithrombotic therapy, as well as a more invasive management strategy.

Entities:  

Mesh：

Year:  2003        PMID： 12801449     DOI： 10.1007/s11886-003-0066-4

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN： 1523-3782            Impact factor:   2.931


  27 in total

1.  Diabetes and acute myocardial infarction: the role of insulin therapy.

Authors:  K Malmberg; D K McGuire
Journal:  Am Heart J       Date:  1999-11       Impact factor: 4.749

Review 2.  Insulin resistance and cardiovascular disease.

Authors:  H N Ginsberg
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

3.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.

Authors:  C P Cannon; W S Weintraub; L A Demopoulos; R Vicari; M J Frey; N Lakkis; F J Neumann; D H Robertson; P T DeLucca; P M DiBattiste; C M Gibson; E Braunwald
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

4.  Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  M I Harris; K M Flegal; C C Cowie; M S Eberhardt; D E Goldstein; R R Little; H M Wiedmeyer; D D Byrd-Holt
Journal:  Diabetes Care       Date:  1998-04       Impact factor: 19.112

5.  Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

Authors:  M J Garcia; P M McNamara; T Gordon; W B Kannel
Journal:  Diabetes       Date:  1974-02       Impact factor: 9.461

6.  Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group V: management of cardiovascular-renal complications.

Authors:  Robert O Bonow; William E Mitch; Richard W Nesto; Patrick T O'Gara; Richard C Becker; Luther T Clark; Sharon Hunt; Ishwarlal Jialal; Stephen E Lipshultz; Evan Loh
Journal:  Circulation       Date:  2002-05-07       Impact factor: 29.690

7.  Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.

Authors:  E J Topol
Journal:  Lancet       Date:  2001-06-16       Impact factor: 79.321

8.  Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction.

Authors: 
Journal:  Lancet       Date:  2001-08-25       Impact factor: 79.321

9.  Glycoprotein IIb/IIIa receptor blockade improves outcomes in diabetic patients presenting with unstable angina/non-ST-elevation myocardial infarction: results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) study.

Authors:  P Théroux; J Alexander; C Pharand; E Barr; S Snapinn; A F Ghannam; F L Sax
Journal:  Circulation       Date:  2000-11-14       Impact factor: 29.690

10.  The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study.

Authors:  R D Abbott; R P Donahue; W B Kannel; P W Wilson
Journal:  JAMA       Date:  1988-12-16       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.